Characterization of C-terminal and Disulfide Bond Peptides of Monoclonal Antibody (mAb) on Q-TOF Mass Spectrometer

Sequence analysis of C-terminal and disulfide-bonds linked peptide for monoclonal antibody was evaluated for a representative biosimilars such as bevacizumab by high resolution mass spectrometer, LCMS-9030 Q-TOF. The sample was reduced, alkylated followed by tryptic digestion. Digested peptides are separated by a reversed-phase chromatography and determined by MS/MS fragmentation with the Q-TOF mass spectrometer. All three C-terminal peptides as well as cysteine congaing peptides expected from bevacizumab biosimilar successfully identified on the extract mass chromatogram with accurate masses within 2 ppm.

Content Type:
Application
Document Number:
AD-0190
Product Type:
Liquid Chromatography, Liquid Chromatograph-Mass Spectrometry, Mass Spectrometry
Keywords:
Peptide mapping, biosimilar, C-terminal sequence, disulfide bond, monoclonal antibody, bevacizumab, Q-TOF, Pharmaceutical, Life Science, LCMS-9030, Nexera Bio
Language:
English
File Name:
apo119142.pdf
File Size:
1,122kb

Free Download

For Research Use Only. Not for use in diagnostic procedures.

This page may contain references to products that are not available in your country. Please contact us to check the availability of these products in your country.

Top of This Page